ConductScience.org, home

Paper4040769

Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro.

Shelley MD and 3 others. Br J Cancer, 1985. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro. Papers, record 4040769. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4040769

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro.
PubMed
Journal
Br J Cancer
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.05
iCite
Revised in PubMed
2019-05-15
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shelley MDM D
2Fish RGR G
3Adams MM
4Kerby II

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CystadenocarcinomaMajor topic
Ovarian NeoplasmsMajor topic
PlatinumMajor topic
Cisplatin
Female
Humans
Kinetics
Time Factors

Source PubMed

Download CSV of topics

References8

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17004139In vitro methods to predict for patient response to chemotherapy.Adv Pharmacol Chemother1980https://conductscience.org/library/papers/7004139PubMed
26791675In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.Br J Cancer1981https://conductscience.org/library/papers/6791675PubMed
37024883Single-agent cis-platinum therapy for advanced ovarian cancer.Obstet Gynecol1981https://conductscience.org/library/papers/7024883PubMed
46539967Total body clearance and platinum accumulation in patients treated with cis-dichlorodiammine platinum (II)Ther Drug Monit1984https://conductscience.org/library/papers/6539967PubMed
56336821"Send this patient's tumor for culture and sensitivity".N Engl J Med1983https://conductscience.org/library/papers/6336821PubMed
66407844Effect of mannitol and plasma on the cytotoxicity of cisplatin.Eur J Cancer Clin Oncol1983https://conductscience.org/library/papers/6407844PubMed
76538459Pharmacokinetics of free and total platinum species after short-term infusion of cisplatin.Cancer Treat Rep1984https://conductscience.org/library/papers/6538459PubMed
87318146Pharmacologic studies of anticancer drugs with the human tumor stem cell assay.Cancer Chemother Pharmacol1981https://conductscience.org/library/papers/7318146PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4040769

GET https://conductscience.org/api/papers/v1/4040769/authors